Endogenous production of infectious Inoue-Melnick virus in a human meningioma cell line

Y Nishibe1, Y K Inoue, A C Hollinshead

  • 1Institute for Virus Research, Kyoto University, Japan.

Insights

Inoue-Melnick virus (IMV) production was studied in human meningioma-derived MG-1 cells. Results show continuous IMV replication and extracellular release, with over 90% of cells expressing viral antigens.

Area of Science:

  • Virology
  • Cell Biology
  • Oncology

Background:

  • The MG-1 cell line originates from human meningioma tissue.
  • Inoue-Melnick virus (IMV) is a type 1 virus with implications for cell culture studies.

Purpose of the Study:

  • To investigate the continuous production of Inoue-Melnick virus (IMV) in the MG-1 cell line.
  • To characterize the replication and release of IMV within this specific cell line.

Main Methods:

  • Cell culture of MG-1 cells derived from human meningioma.
  • Infectious virus recovery assays.
  • Infective center assays.
  • Immunofluorescence staining for IMV-associated cytoplasmic antigens (IMCA).

Main Results:

  • Continuous production of IMV was achieved in the MG-1 cell line.
  • Infectious IMV was predominantly recovered extracellularly.
  • Over 90% of MG-1 cells exhibited IMV-associated cytoplasmic antigens (IMCA) via immunofluorescence.
  • Infective center assays confirmed widespread viral production capability among MG-1 cells.

Conclusions:

  • The MG-1 cell line supports robust and continuous replication of Inoue-Melnick virus.
  • MG-1 cells are highly susceptible to IMV infection, with most cells actively producing and releasing the virus.
  • This cell line serves as a valuable model for studying IMV biology and pathogenesis.